Roslund, Kajsa
Lehto, Markku
Pussinen, Pirkko
Hartonen, Kari
Groop, Per-Henrik
Halonen, Lauri
Metsälä, Markus
Funding for this research was provided by:
Wilhelm och Else Stockmanns Stiftelse
CHEMS Doctoral Program of the University of Helsinki
Suomen Hammaslääkäriseura Apollonia
Sigrid Juséliuksen Säätiö
Academy of Finland
Folkhälsanin Tutkimussäätiö
Helsinki University Central Hospital Research Funds
Article History
Received: 22 February 2021
Accepted: 6 August 2021
First Online: 19 August 2021
Competing interests
: PHG has received research grants from Eli Lilly and Roche, lecture fees from Astellas, Astra Zeneca, Boehringer-Ingelheim, Eli Lilly, Elo Water, Genzyme, M.S.D., Mundipharma, Novartis, Novo Nordisk, and Sanofi. He is an advisory board member for AbbVie, Boehringer-Ingelheim, Eli Lilly, Janssen, Medscape, Mundipharma, Novartis, Novo Nordisk, and Sanofi. All other authors declare that there is no conflict of interest.